The cost of equipment required for labelling drugs on one production line of a pharmaceutical plant does not exceed €150,000. This was reported in an interview with TASS by Dmitry Morozov, General Director of Biocad, a Russian biotech company.
„The maximum investment (for equipment of each production line – editor’s note) is up to 150 thousand euro. Pharmaceutical companies can afford this amount. If there are pharmaceutical companies that cannot afford such costs, it looks strange that they exist at all,” said Mr. Morozov.
According to additional information provided by the press service of the company, a code reading scanner for pharmacies will cost to the company about 20 thousand rubles.
Mr. Morozov also noted that the implementation of labelling will not affect the price of drugs for the end consumers. “This (the labelling – editor’s note) will make the market more transparent,” said the General Director of Biocad but he added that it is just not profitable for some market participants.